Multiple Myeloma Market Snapshot: New Drugs And Big Changes

The multiple myeloma treatment landscape is poised for a shakeup following the FDA approval of three new drugs to treat the incurable cancer, but with all the competition, determining which drugs to use when and in which patients won’t necessarily be straightforward.

More from Clinical Trials

More from R&D